Taprenepag isopropyl 7016 [2H]C([2H])([2H])N(CC(O)=O)C(N)=N

[2H]C([2H])([2H])N(CC(O)=O)C(N)=N

BX-471 was undergoing phase I trials for the potential treatment of autoimmune diseases

2010 Oct 1

InChi: InChI=1S/C62H84N14O6/c1-41(63-3)57(77)65-49-27-13-11-25-47-33-35-53(75(47)61(49)81)59(79)67-55(45-21-7-5-8-22-45)51-39-73(71-69-51)37-17-15-19-43-29-31-44(32-30-43)20-16-18-38-74-40-52(70-72-74)56(46-23-9-6-10-24-46)68-60(80)54-36-34-48-26-12-14-28-50(62(82)76(48)54)66-58(78)42(2)64-4/h5-10

4-diol hydrochloride

Taprenepag isopropyl 7016 [2H]C([2H])([2H])N(CC(O)=O)C(N)=NTaprenepag isopropyl is a highly selective EP2 receptor agonist. Product information CAS Number: 1005549 94 9 Molecular Weight: 520. 60 Formula: C27H28N4O5S Chemical Name: propan 2 yl 2 {3 [(N {[4 (1H pyrazol 1 yl)phenyl]methyl}pyridine 3 sulfonamido)methyl]phenoxy}acetate Smiles: CC(C)OC(=O)COC1C=C(CN(CC2C=CC(=CC=2)N2C=CC=N2)S(=O)(=O)C2=CN=CC=C2)C=CC=1 InChiKey: NVPXUFQLKWKBHK UHFFFAOYSA N InChi: InChI=1S C27H28N4O5S c1 21(2)36 27(32)20 35 25 7 3 6